Diabetes in pregnancy has been increasing in the United States. Most of the increase is due to gestational diabetes. However, pre-existing type 2 diabetes in pregnancy is rising secondary to the childhood obesity epidemic. Both uncontrolled pregestational type 1 and type 2 diabetes confer significant health risks to the mother and fetus. These risks include preeclampsia, fetal death, preterm births, macrosomia, congenital anomalies, neonatal hyperbilirubinemia, and hypoglycemia. Ideally, optimal blood glucose control in the mother is required at least three months before conception, but glucose control is needed throughout the pregnancy and postnatally for optimal lactation.
CooperSoft is working with Howard University Hospital and Dexcom to develop a mobile app that will upload glucose test results, record A1c-level, send text reminders for testing, follow-up visits, dietary guidelines in maternal care. The app will allow the mother to record breastfeeding, or breast milk pumping sessions, receive support strategies to encourage pumping and or feeding, techniques to maintain breast milk volume and increase breastfeeding duration.